To our knowledge, this is the first study to detect a genetic moderation (using APOE and AD-GRS) with modifiable risk scores (risk indicators: BMI, PP, grip strength, daily lifestyle activities, and education) on EF performance and change. The gene discussed is APOE; the disease is Alzheimer disease.